Source: MarketScreener

Leap Therapeutics: Leap Therapeutics : to Present at H.C. Wainwright 22nd Annual Global Investment Conference

( CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 22nd Annual Global Investment Conference,...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Chris Mirabelli's photo - CEO of Leap Therapeutics


Chris Mirabelli

CEO Approval Rating


Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more